Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0190 | ||||
| Gene Name | SLC25A29 | ||||
| Protein Name | Mitochondrial ornithine transporter 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | C14orf69; CACL; CACT-like; Carnitine/acylcarnitine translocase-like; Mitochondrial basic amino acids transporter; Mitochondrial carnitine/acylcarnitine carrier protein CACL; ORNT3; SLC25A29; Solute carrier family 25 member 29 | ||||
| DT Family | Mitochondrial Carrier (MC) Family ; | ||||
| Function | This transporter transports arginine, lysine, homoarginine, methylarginine and, to a much lesser extent, ornithine and histidine. Can restore ornithine transport in cells lacking the primary mitochondrial ornithine transporter SLC25A15. Does not transport carnitine nor acylcarnitines. Functions by both counter-exchange and uniport mechanisms. | ||||
| Endogenous Substrate(s) | Methylarginine | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Arginine
|
Approved | Drug Info | Growth hormone deficiency | 5A61 | [1] |
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
L-homoarginine
|
Preclinical | Drug Info | Acute ischemic stroke | 8B11 | [1] |
|
Lysine
|
Preclinical | Drug Info | Schizophrenia | 6A20 | [1] |
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Arginine | Approved | Drug Info | SLC25A29-reconstituted Liposomes | Km = 420 microM | [1] |
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Lysine | Preclinical | Drug Info | SLC25A29-reconstituted Liposomes | Km = 710 microM | [1] |
| References | |||||
| 1 | The human gene SLC25A29, of solute carrier family 25, encodes a mitochondrial transporter of basic amino acids. J Biol Chem. 2014 May 9;289(19):13374-84. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.